Company Update (NYSE:JNJ): Johnson & Johnson’s forex warning a sign for rival drugmakers

[Reuters] – Johnson & Johnson surprised investors by detailing the degree to which a strong dollar will hurt sales abroad this year, and industry watchers say Wall Street is underestimating the likely hit . . . → Read More: Company Update (NYSE:JNJ): Johnson & Johnson’s forex warning a sign for rival drugmakers Similar Articles: Stock Update (NYSE:PFE): FDA panel votes to keep severe warning on Pfizer anti-smoking drug Market Update: Pfizer Inc (NYSE:PFE) – FDA staff wants Pfizer to keep black box warning on anti-smoking drug Company Update (NYSE:UNH): UnitedHealth to buy doctor management company MedSynergies